seasonal flu vaccines
Scope
Date
~
-
Leadership & Management
Samsung mobile chief fills leadership void in device division
Samsung Electronics Co. has appointed TM Roh, president and head of its mobile eXperience (MX) business, as the new chief of its device eXperience (...
Apr 02, 2025 (Gmt+09:00)
-
Korean chipmakers
SK Hynix’s HBM exports plummet, now susceptible to seasonal demand
Exports of SK Hynix Inc.'s multi-chip packages (MCP), including high-bandwidth memory (HBM) AI chips, are rapidly dropping as the South Korean chipm...
Feb 10, 2025 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines
South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
Dec 23, 2024 (Gmt+09:00)
-
Automobiles
Kia reveals teaser images of The New Sportage
South Korea's Kia Corp. unveiled the teaser images and videos of The New Sportage, the facelift model of Kia's flagship compact sport utility vehicl...
Oct 24, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
Oct 24, 2024 (Gmt+09:00)
-
Investment banking
Junior bankers choosing track records over name value
A number of junior bankers at the Korean offices of major global investment banks such as Morgan Stanely and J.P.Morgan have resigned since July wit...
Aug 30, 2024 (Gmt+09:00)
-
Korean startups
Enormous market ahead for Hopae, S.Korean DID pioneer
To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...
Aug 22, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience sells stake in US vaccine developer Novavax
SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...
Aug 16, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn
South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...
Jun 27, 2024 (Gmt+09:00)
-
Bio & Pharma
EuBiologics gets WHO certification for cholera vaccine facility
South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...
May 17, 2024 (Gmt+09:00)
-
Entertainment
Hasty overseas expansion hurts Korean entertainment sector
South Korea’s entertainment and content industries suffered from hasty expansions with investments of billions of dollars in the global market...
May 07, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience exports Sky Cellflu to Thailand
South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...
Mar 21, 2024 (Gmt+09:00)
-
Artificial intelligence
LG to use AI for early detection of air conditioner anomalies
LG Electronics Inc. has introduced an artificial intelligence technology for early detection of anomalies in its commercial air conditioning systems...
Feb 20, 2024 (Gmt+09:00)
-
Automobiles
Hankook Tire unveils all-season tire Kinergy XP in N.America
South Korea's Hankook Tire & Technology announced on Wednesday that it will launch its all-season grand touring tire Kinergy XP in the North Ame...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience start to deliver Novavax COVID-19 vaccine
South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...
Dec 12, 2023 (Gmt+09:00)
-
Entertainment
Toho buys 25% stake in CJ ENM’s Fifth Season for $225 mn
Toho Co. has acquired a 25% stake in Fifth Season for $225 million, a move expected to be a win for not only the money-losing US-based producer-dist...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Nov 22, 2023 (Gmt+09:00)
-
Earnings
Korean tire makers post double-digit Q3 profit margins; outlook bright
South Korea’s three leading tire makers posted their highest-ever quarterly profit margins in the third quarter, boosted by tire price hikes, ...
Nov 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean vaccine developer Quratis eyes Iraqi market
South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...
Oct 12, 2023 (Gmt+09:00)
-
Travel & Leisure
Overseas trips top pre-pandemic levels during Chuseok holiday
The number of South Koreans who spent this year’s six-day holiday of Chuseok abroad exceeded pre-pandemic levels, indicating a recovery in the...
Oct 08, 2023 (Gmt+09:00)
-
Bio & Pharma
EuBiologics, GC Biopharma to jointly produce cholera vaccine
South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...
Aug 25, 2023 (Gmt+09:00)
-
Bio & Pharma
POSCO Int'l marks 1st animal vaccine exports
POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience resumes output of flu vaccine after two years
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to export $51 bn flu vaccine to Thailand
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...
Aug 21, 2023 (Gmt+09:00)
-
Airlines
Korean Air’s operating profit falls to $360 mn in Q2 2023
Korean Air Lines Co.’s operating profit in the second quarter fell over 30% from the same period last year in line with market consensus.Consi...
Aug 03, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem to make first domestic 6-in-1 vaccine for infants
South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...
Aug 01, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand